This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1991 Feb;9(1):77-8.

doi: 10.1007/BF00194550.

Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study

T D Brown¹, P J Goodman, T R Fleming, L H Baker, J S Macdonald

Affiliations

PMID: 1827433
DOI: 10.1007/BF00194550

Clinical Trial

Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study

T D Brown et al. Invest New Drugs. 1991 Feb.

. 1991 Feb;9(1):77-8.

doi: 10.1007/BF00194550.

Authors

T D Brown¹, P J Goodman, T R Fleming, L H Baker, J S Macdonald

Affiliation

¹ University of Texas Health Science Center, San Antonio.

PMID: 1827433
DOI: 10.1007/BF00194550

No abstract available

PubMed Disclaimer

Similar articles

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Sessa C, Kaye SB, Renard J, ten Bokkel Huinink W, Cavalli F. Sessa C, et al. Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9. Eur J Cancer Clin Oncol. 1989. PMID: 2523809 No abstract available.
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Gundersen S, Monfardini S, Renard G, Van Glabbeke M, Pinedo H. Gundersen S, et al. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1707-8. doi: 10.1016/0277-5379(87)90454-8. Eur J Cancer Clin Oncol. 1987. PMID: 2962875 No abstract available.
Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study.
Vance RB, Crowley JJ, Macdonald JS, Ahmann FR. Vance RB, et al. Invest New Drugs. 1991 Feb;9(1):73-5. doi: 10.1007/BF00194549. Invest New Drugs. 1991. PMID: 1851143 Clinical Trial.
The biochemical pharmacology of nogalamycin and its derivatives.
Li LH, Krueger WC. Li LH, et al. Pharmacol Ther. 1991;51(2):239-55. doi: 10.1016/0163-7258(91)90080-6. Pharmacol Ther. 1991. PMID: 1838416 Review.
New anticancer agents.
Weiss GR, Arteaga CL, Brown TD, Craig JB, Harman GS, Havlin KA, Koeller JM, Kuhn JG, Von Hoff DD. Weiss GR, et al. Cancer Chemother Biol Response Modif. 1988;10:85-116. Cancer Chemother Biol Response Modif. 1988. PMID: 2484323 Review. No abstract available.

See all similar articles

References

1. Biometrics. 1982 Mar;38(1):143-51 - PubMed
1. Cancer Res. 1979 Dec;39(12):4849-55 - PubMed
1. Cancer Res. 1986 May;46(5):2562-5 - PubMed
1. Cancer. 1981 Jan 1;47(1):207-14 - PubMed
1. Am J Clin Oncol. 1988 Apr;11(2):174-6 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

etc

LinkOut - more resources

Medical
- MedlinePlus Health Information